SEC Form 4 · accession 0000899243-18-027179
Arcus Biosciences, Inc. · RCUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kristen Hege
Director
Period of report
Oct 19, 2018
Accepted (ET)
Oct 22, 2018 · 7:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001724521
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.79 | Oct 19, 2018 | A | 35,000 | A | — | Oct 18, 2028 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1The option is exercisable in 36 equal monthly installments after October 19, 2018, subject to the Reporting Person's continued service to the Company.